Hart TK - Search Results

1

Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice.

Hepburn TW, Hart TK, Horton VL, Sellers TS, Tobia LP, Urbanski JJ, Shi W, Davis CB. Hepburn TW, et al. Among authors: hart tk. J Pharmacol Exp Ther. 2001 Sep;298(3):886-93. J Pharmacol Exp Ther. 2001. PMID: 11504781

2

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB. Zia-Amirhosseini P, et al. Among authors: hart tk. J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7. J Pharmacol Exp Ther. 1999. PMID: 10565825

3

Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.

Sharma A, Davis CB, Tobia LA, Kwok DC, Tucci MG, Gore ER, Herzyk DJ, Hart TK. Sharma A, et al. Among authors: hart tk. J Pharmacol Exp Ther. 2000 Apr;293(1):33-41. J Pharmacol Exp Ther. 2000. PMID: 10734150

4

Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.

Davis CB, Hepburn TW, Urbanski JJ, Kwok DC, Hart TK, Herzyk DJ, Demuth SG, Leland M, Rhodes GR. Davis CB, et al. Among authors: hart tk. Drug Metab Dispos. 1995 Oct;23(10):1028-36. Drug Metab Dispos. 1995. PMID: 8654189

5

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.

Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, Eustis S, Schwartz LW, Tsui P, Appelbaum ER, Martin EC, Bugelski PJ, Herzyk DJ. Hart TK, et al. J Allergy Clin Immunol. 2001 Aug;108(2):250-7. doi: 10.1067/mai.2001.116576. J Allergy Clin Immunol. 2001. PMID: 11496242

6

Flow cytometry in the preclinical development of biopharmaceuticals.

Gossett KA, Narayanan PK, Williams DM, Gore ER, Herzyk DJ, Hart TK, Sellers TS. Gossett KA, et al. Among authors: hart tk. Toxicol Pathol. 1999 Jan-Feb;27(1):32-7. doi: 10.1177/019262339902700107. Toxicol Pathol. 1999. PMID: 10367670 Review.

7

Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.

Underwood DC, Bochnowicz S, Osborn RR, Luttmann MA, Louden CS, Hart TK, Elliott JD, Hay DW. Underwood DC, et al. Among authors: hart tk. Pulm Pharmacol Ther. 1999;12(1):13-26. doi: 10.1006/pupt.1999.0158. Pulm Pharmacol Ther. 1999. PMID: 10208832

8

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.

Hart TK, Blackburn MN, Brigham-Burke M, Dede K, Al-Mahdi N, Zia-Amirhosseini P, Cook RM. Hart TK, et al. Clin Exp Immunol. 2002 Oct;130(1):93-100. doi: 10.1046/j.1365-2249.2002.01973.x. Clin Exp Immunol. 2002. PMID: 12296858 Free PMC article.

9

Preclinical safety of recombinant human interleukin-18.

Herzyk DJ, Bugelski PJ, Hart TK, Wier PJ. Herzyk DJ, et al. Among authors: hart tk. Toxicol Pathol. 2003 Sep-Oct;31(5):554-61. doi: 10.1080/01926230390226681. Toxicol Pathol. 2003. PMID: 14692624

10

Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.

Taylor G, Porter T, Dillon S, Trill J, Ganguly S, Hart T, Davis C, Wyde P, Tempest P, Harris W. Taylor G, et al. Biochem Soc Trans. 1995 Nov;23(4):1063-7. doi: 10.1042/bst0231063. Biochem Soc Trans. 1995. PMID: 8654682 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters